Literature DB >> 3606679

Is anticardiolipin activity a cross-reaction of anti-DNA or a separate entity?

R J Smeenk, W A Lucassen, T J Swaak.   

Abstract

Putative cross-reactions between anti-DNA and anticardiolipin activities were studied using sera of different patients and a panel of monoclonal antibodies to DNA. Sera were obtained from patients with systemic lupus erythematosus, from patients with syphilis, and from heroin addicts who showed a biologic false-positive result on the serologic test for syphilis. While the patients with syphilis and the heroin addicts had elevated levels of anticardiolipin antibodies in their circulation, no reactivity with DNA was observed in these sera. Sera from systemic lupus erythematosus patients often showed both anti-DNA and anticardiolipin activity. Although a correlation between anti-DNA and anticardiolipin titers was found, this did not always result from cross-reactivity of the same population of antibodies. In fact, we observed a relationship between cross-reactivity and antibody avidity. Anti-DNA of high avidity to DNA showed little cross-reactivity with cardiolipin. Anticardiolipin activity in such sera was based on the presence of specific anticardiolipin antibodies. Anti-DNA of low avidity was found to cross-react with cardiolipin. Among monoclonal antibodies to DNA, we found that cross-reactions with cardiolipin were rare: only 6 of 55 anti-DNA clones produced antibodies that also reacted with cardiolipin.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3606679     DOI: 10.1002/art.1780300602

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  26 in total

1.  Relation between serological data at the time of biopsy and renal histology in lupus nephritis.

Authors:  J C Nossent; S C Henzen-Logmans; T M Vroom; V Huysen; J H Berden; A J Swaak
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

Review 2.  Lessons about autoantibody specificity in systemic lupus erythematosus from animal models.

Authors:  D I Stott
Journal:  Clin Exp Immunol       Date:  1990-07       Impact factor: 4.330

3.  Phospholipid in the hexagonal II phase is immunogenic: evidence for immunorecognition of nonbilayer lipid phases in vivo.

Authors:  J Rauch; A S Janoff
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

4.  Evidence for direct anti-heparin-sulphate reactivity in sera of SLE patients.

Authors:  K Pirner; A Rascu; W Nürnberg; A Rubbert; J R Kalden; B Manger
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

5.  False positive ELISA tests for anticardiolipin antibodies in sera from patients with repeated abortion, rheumatologic disorders and primary biliary cirrhosis: correlation with elevated polyclonal IgM and implications for patients with repeated abortion.

Authors:  S Cowchock; J Fort; S Munoz; R Norberg; W Maddrey
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

6.  Monoclonal anticardiolipin antibodies derived from mice with experimental lupus erythematosus: characterization and the induction of a secondary antiphospholipid syndrome.

Authors:  Z M Sthoeger; B Tartakovsky; Z Bentwich; E Mozes
Journal:  J Clin Immunol       Date:  1993-03       Impact factor: 8.317

7.  The serology and immunochemistry of HIV-induced platelet-bound immunoglobulin.

Authors:  R J Klaassen; J van der Lelie; A B Vlekke; H M Weigel; J K Eeftinck Schattenkerk; P Reiss; A E von dem Borne
Journal:  Blut       Date:  1989-07

8.  Higher anti-heparan sulphate reactivity during systemic lupus erythematosus (SLE) disease exacerbations with renal manifestations; a long term prospective analysis.

Authors:  C Kramers; R M Termaat; E J ter Borg; M C van Bruggen; C G Kallenberg; J H Berden
Journal:  Clin Exp Immunol       Date:  1993-07       Impact factor: 4.330

9.  Antiphospholipid antibodies in systemic lupus erythematosus: clinical and laboratory associations in 111 patients.

Authors:  Y Wang; L Schrieber; M G Cohen; L Furphy; J Webb; T Chivers; K M Pollard
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

10.  The H3 anti-phospholipid idiotype is found in patients with systemic lupus erythematosus (SLE) but not in patients with syphilis.

Authors:  A Hohmann; R Comacchio; V Boswarva; M Sutjita; J Bradley
Journal:  Clin Exp Immunol       Date:  1991-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.